Coil Embolization of Septal Branches inHypertrophic Obstructive Cardiomyopathy = KISEP CASE REPORT Korean Circulation J 200434(7):706-710 Coil Embolization of Septal Branches in Hypertrophic Obstructive Cardiomyopathy

다국어 초록 (Multilingual Abstract)

Hypertrophic cardiomyopathy (HCM) has been associated with sudden death in young athletes. On long-termfollow up, syncope, chest pain and dyspnea are well known frequent symptoms due to the dynamic left ventricularoutflow tract (LVOT) obstruction, mitral regurgitation and diastolic dysfunction. To reduce the LVOT pressuregradient, septal myectomy and alcohol injection have recently been utilized. However, some complications havebeen reported with alcohol ablation of the septal branches, such as complete atrioventricular block and alcoholspill over to ablate the entire left anterior descending coronary artery. Herein, a case of coil embolization of theseptal branches, with successful reduction of the LVOT pressure gradient, is reported in a patient with HOCM.

참고문헌 (Reference)

1 "Transcoronary ablation of septal hypertrophy(TASH) a new treatment option for hypertrophicobstructive cardiomyopathy" 89 (89): IV41-54, 2000

2 "The managementof hypertrophic cardiomyopathy" 336 : 775-785, 1997

3 "The cardiomyopathies and myocarditides.In: Braunwald E, Zipes DP, Libby P, editors.Heart Disease: a textbook of cardiovascular medicine" Philadelphia: W.B Saunders company 1760-1774, 2001

4 "Pressure-guided nonsurgical myocardialreduction indeced by small septal infarctions in hypertrophicobstructive cardiomyopathy" 38 : 846-853, 2001

5 "Predictors of outcome after alcohol septal ablationtherapy in patients with hypertrophic obstructive cardiomyopathy" 109 : 824-827, 2004

6 "Percutaneous transluminalseptal myocardial ablation in hypertrophic obstructivecardiomyopathy: results with respect to intraproceduralmyocardial contrast echocardiography" 98 : 2415-2421, 1998

7 "Percutaneous transluminal septal myocardialablation in hypertrophic obstructive cardiomyopathy:acute results and 3-month follow-up in 25 patients" 31 : 252-258, 1998

8 "New concepts in hypertrophic cardiomyopathies,part II" 104 : 2249-2252, 2001

9 "Impact of infarct size on clinical and echocardiographicoutcome in patients undergoing nonsurgicalseptal reduction theraphy" 146 : 1112-1114, 2003

10 "Hypertrophiccardiomyopathy: clinical spectrum and treatment" 92 : 1680-1692, 1995

11 "Effect of left ventricular outflow tract obstructionon clinical outcome in hypertrophic cardiomyopathy" 348 : 295-303, 2003

12 "Early and long-termresults of non-surgical septal reduction in patients withhypertrophic cardiomyopathy" 59 : 269-282, 2003

13 "Completeheart block: determinants and clinical impact in patientswith hypertrophic obstructive cardiomyopathy undergoingnonsurgical septal reduction therapy" 42 : 296-300, 2003

14 "Clinical and morphological features of hypertrophic cardiomyopathyin Korean patients" 4 : 163-169, 1989